Kristen Rosati Plans and Moderates AHLA Convener Session on AI in Healthcare

Kristen Rosati Explains De-Identification at Privacy and Security Academy Workshop

A complicated web of laws regulates de-identification, including U.S. federal laws, state laws and the EU General Data Protection Regulation. During a workshop for the Privacy and Security Academy, Kristen Rosati provided a comprehensive overview of these overlapping regulations as well as a more in-depth look at HIPAA de-identification and associated challenges. Kristen’s presentation explored the HIPAA Privacy Rule de-identification methods, including expert determination and safe harbor. She also explained when genetic information is considered protected health information, and the prospect of the Common Rule treatment of genetic information identifiability changing over time. Finally, Kristen discussed “future proofing” data for evolving standards of de-identification. As a highly regarded “Big Data” and HIPAA compliance attorney, Kristen is a frequent speaker on topics related to health information exchange, health...

Read MoreRead More
Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati addressed the National Academies of Science, Engineering and Medicine National Cancer Policy Forum workshop on the role of digital health applications in oncology research and care. Kristen’s presentation addressed legal considerations around patient privacy and data security, in digital health applications. One of the nation’s leading “Big Data” and HIPAA compliance attorneys, Kristen focused on how the patient right of access, the patient right to direct disclosures to third parties, and the new information blocking and interoperability rules affect oncology digital health apps. She also provided an overview of privacy requirements for data sharing in cancer treatment and research, discussing the evolving standards for de-identification of genomic information.  With deep experience in data sharing for research and clinical integration initiatives, clinical research compliance, and biobanking and genomic...

Read MoreRead More
Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati Discusses De-identification Legal Standards During AHLA Webinar

As a nationally recognized leader in health information privacy and security, Coppersmith Brockelman’s Kristen Rosati was asked to participate in a 90-minute webinar “De-identification Demystified: Legal Standards, Risks, and Mechanisms to Prevent Re-identification” for the American Health Law Association (AHLA). Kristen explained the evolving legal standards for the de-identification or anonymization of data under various privacy laws, including HIPAA, 42 C.F.R. Part 2, the Common Rule, the California Consumer Privacy Act, and the European Union General Data Protection Regulation. She also discussed how to “future proof” de-identified data during this time of changing legal standards, through using the statistical expert method of de-identification.  A Past President of AHLA, Kristen is a respected mainstay within the nation’s largest educational organization devoted to legal issues in the health care field.  Kristen...

Read MoreRead More